Clinical Trial Update: Nab-paclitaxel and Gemcitabine Hydrochloride Followed by Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nab-paclitaxel and gemcitabine hydrochloride followed by radiation therapy prior to surgery in resectable pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer

Drugs mentioned

• Gemcitabine hydrochloride (Gemcitabine hydrochloride)
• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Pancreatic Adenocarcinoma, Resectable Pancreatic Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2021-01-14